Quantitative evaluation of DSS-induced colitis with AI: a new tool to assess drug candidates for IBDAccess now
In EU and EEA countries Aiforia® Clinical is CE marked under the EU’s In Vitro Diagnostic Device Regulation 2017/746 for in vitro diagnostic use. In the USA, Japan, and other countries Aiforia® Clinical is for research use only and is not for use in diagnostic procedures.
*Aiforia's AI models and AI development platform, Aiforia Create, are currently sold with Research Use Status.
The browser-based Aiforia Clinical viewer removes the need to store or ship physical slides and there is no need for dedicated hardware to use the browser software.